Neil Tween Appointed CFO of Owlstone Medical
Neil Tween joins Owlstone Medical from GW Pharmaceuticals, a publicly listed (NASDAQ: GWPH) pharmaceutical company, where he served as Vice President and Group Financial Controller.
FDA Expedites Review of Diagnostic Tests to Combat COVID-19
The FDA has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the U.S.
Reprocessing N95 Masks With STERRAD: Protects Healthcare Workers in the Battle Against COVID-19
The evolution of the COVID-19 pandemic has created a mass shortage of N95 masks for healthcare professionals around the world. ASP qualified a protocol for reprocessing select N95 masks so hospitals can triple the lifespan of the mask using the STERRAD® Sterilizers already in healthcare facilities today to reprocess up to 480 masks per STERRAD® Sterilizer machine daily to help healthcare professionals combat the spread of coronavirus.
Fractyl Laboratories Announces New REVITA-2 Study Clinical Data
Data presented at ENDO 2020 from the randomized, sham-controlled REVITA-2 study verifies that improvements in blood glucose control (HbA1C), insulin sensitivity, and other metabolic measures seen after one Revita treatment are also associated with improved pancreatic beta-cell function notes Fractyl Laboratories.
FDA Approves Next-Generation ZOLL TherOx System for Widowmaker Heart Attack Patients
The second-generation ZOLL TherOx System provides SuperSaturated Oxygen (SSO2) Therapy and reduces heart muscle damage in “widowmaker” heart attack patients.